Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).
about
Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolutionIntensive care for cancer patientsGranulocyte transfusion: questions remainBloodstream infections in neutropenic cancer patients: A practical update.Sepsis in the severely immunocompromised patient.Multidrug-resistant bacteria in hematology patients: emerging threats.Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients.Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Association between early peak temperature and mortality in neutropenic sepsis.[Rational use of antibiotics].Improving the outcome of bloodstream infection in patients with hematological malignancies: looking beyond antibiotics.Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre.Prognostic factors in the survival of patients with blood disorders recovering from septic shock.Cerenkov-Activated Sticky Tag for In Vivo Fluorescence Imaging.Consensus statement for cancer patients requiring intensive care support.Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.
P2860
Q24185821-6FDDBFE5-21C4-4A4E-85FC-20B0EDD27313Q26749059-95286BE1-4B20-4E80-8B8E-17120C9D62DCQ36225159-7EC4A83F-9ADC-48EA-A964-1FFA1F673C10Q36913345-63E02639-0115-416E-8C86-E83D573C9BD7Q38458270-F78F352E-7156-4E75-83FA-70A38D7C9322Q38838498-B7963A34-2259-4D16-9AAD-4C13DFCA30A8Q38935459-9FE83469-C228-4069-9EFF-8615670087DDQ38952110-BAAC1CF4-A28B-4F91-AA89-0AC40E09EC66Q39283415-84FE0033-50AD-41E8-8AEA-6363F78B449DQ40041299-6B50A8ED-87D3-47D9-8F44-519F05E90194Q40177550-E54565EA-7116-44F7-ADBB-D7615759AEC4Q40651143-B40F345F-95ED-49A6-981A-D4A15266DEFCQ41151969-C229C8AA-1703-43E4-8489-78AFC85F2DA0Q41922277-B8BC198C-F89E-4F80-9598-E559224381E2Q47630011-328B12DB-7614-423B-AEFA-D72897FAB8E4Q48660715-BBEACE3E-BB37-4C2C-8DD5-D9C50DA4D01EQ55049916-9F1EAEF6-F363-4183-A0D2-C9946DD33482Q55092273-B6880F56-A04C-4381-BEB6-AD872164EB7E
P2860
Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of sepsis in neutro ...... and Medical Oncology (AGIHO).
@en
type
label
Management of sepsis in neutro ...... and Medical Oncology (AGIHO).
@en
prefLabel
Management of sepsis in neutro ...... and Medical Oncology (AGIHO).
@en
P2093
P2860
P50
P921
P1433
P1476
Management of sepsis in neutro ...... y and Medical Oncology (AGIHO)
@en
P2093
Carolin Becker
Enrico Schalk
Helmut Ostermann
Marc Reinwald
Marcus Hentrich
Marie von Lilienfeld-Toal
Martin Schmidt-Hieber
Michael Kiehl
Olaf Penack
Thomas Weber
P2860
P304
P356
10.1007/S00277-014-2086-0
P577
2014-04-29T00:00:00Z